aTyr Pharma (LIFE) Misses Q1 EPS by 11c
aTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.44), $0.11 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
aTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.44), $0.11 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.